| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
22,900,000 |
| Market
Cap: |
29.54(M) |
| Last
Volume: |
145,865 |
Avg
Vol: |
145,472 |
| 52
Week Range: |
$1.275 - $3.61 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Hardware |
| Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile iCAD is a medical technology company providing cancer detection and therapy solutions. Co.'s segments are: Cancer Detection, which includes image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint prevalent cancers earlier, and various Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, which provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
38,960 |
| Total Sell Value |
$0 |
$0 |
$0 |
$106,653 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sallam Maha |
Executive Vice President |
• • – |
2004-09-17 |
4 |
S |
$3.49 |
$3,845 |
D/D |
(1,100) |
1,958,695 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-09-16 |
4 |
S |
$3.61 |
$5,412 |
D/D |
(1,500) |
1,959,795 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-09-14 |
4 |
S |
$3.57 |
$9,639 |
D/D |
(2,700) |
1,961,295 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-09-13 |
4 |
S |
$3.50 |
$52,568 |
D/D |
(15,000) |
1,963,995 |
|
- |
|
| Rogers Steven K |
Chief Scientific Officer |
• • – |
2004-08-18 |
4 |
S |
$3.11 |
$64,787 |
D/D |
(20,000) |
980,754 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-08-16 |
4 |
S |
$3.35 |
$6,700 |
D/D |
(2,000) |
0 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-08-13 |
4 |
S |
$3.30 |
$1,155 |
D/D |
(350) |
1,978,995 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-08-12 |
4 |
S |
$3.38 |
$2,704 |
D/D |
(800) |
1,979,345 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-08-10 |
4 |
S |
$3.35 |
$3,350 |
D/D |
(1,000) |
2,000 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2004-08-10 |
4 |
S |
$3.34 |
$8,350 |
D/D |
(2,500) |
1,980,145 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-08-06 |
4 |
S |
$3.35 |
$3,350 |
D/D |
(1,000) |
3,000 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-08-05 |
4 |
S |
$3.35 |
$10,362 |
D/D |
(3,081) |
4,000 |
|
- |
|
| Howard Robert |
Director |
– • • |
2004-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
33,700 |
2,953,163 |
|
- |
|
| Shoup Thomas E |
Vice President,Staff Operation |
• – – |
2004-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247,069 |
|
- |
|
| Farrell Peter |
Vice President Sales&Marketing |
• – – |
2004-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
110,807 |
|
- |
|
| Sussman Elliot J Md Mba |
Director |
– • – |
2004-05-18 |
4 |
OE |
$1.55 |
$23,250 |
D/D |
15,000 |
18,000 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-04-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,081 |
|
- |
|
| Sklaroff Herschell |
Director |
– • – |
2004-04-13 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
7,081 |
|
- |
|
| Corbett James L |
Chief Operating OfficerOfficer |
• • – |
2004-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247,069 |
|
- |
|
| Rogers Steven K |
Chief Scientific OfficerOffice |
• • – |
2004-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000,754 |
|
- |
|
| Howard Robert |
Director |
– • • |
2004-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
2,986,863 |
|
- |
|
| Heroux Annette |
Chief Financial Officer |
• – – |
2003-12-12 |
4 |
S |
$5.27 |
$44,302 |
D/D |
(8,400) |
3,000 |
|
- |
|
| Heroux Annette |
Chief Financial Officer |
• – – |
2003-12-12 |
4 |
OE |
$0.81 |
$6,825 |
D/D |
8,400 |
11,400 |
|
- |
|
| Woods Kevin |
Vice President, Research & Dev |
• • – |
2003-12-12 |
4 |
S |
$5.30 |
$26,500 |
D/D |
(5,000) |
1,295,889 |
|
- |
|
| Sallam Maha |
Executive Vice President |
• • – |
2003-12-11 |
4 |
S |
$5.22 |
$105,688 |
D/D |
(20,100) |
1,982,645 |
|
- |
|
459 Records found
|
|
Page 18 of 19 |
|
|
0.02 (1.53%) 
